How did BD Medical's revenue and expenses trend in Q1 2025?

BD Medical's revenue and expenses in Q1 2025 showed notable growth and strategic shifts, reflecting the company's focus on expanding its medical technology offerings and optimizing its operations. 1. **Revenue Growth**: BD Medical's worldwide revenues increased by 17.3% to $2.62 billion. This growth was driven by strong performances across its business units, particularly in Medication Delivery Solutions and Medication Management Solutions. The organic revenue change was 5%, indicating a solid base of existing business operations. 2. **Expense Management**: The company's focus on cost management is evident in the reported financial results. While specific expense figures are not detailed, the adjustments made to the adjusted earnings per share (EPS) calculation, which included expenses related to purchase accounting adjustments and integration costs, suggest a proactive approach to managing incremental costs associated with business acquisitions and strategic initiatives. 3. **Segment Performance**: The MDS and MMS business units were particularly notable for their contribution to the organic revenue growth, reflecting the success of BD Medical's product portfolio and market positioning in these segments. 4. **Currency Impact**: The company's revenues were also positively influenced by a 9.6% currency-neutral growth, which suggests effective management of foreign currency risks and strategic positioning in international markets. In summary, BD Medical's Q1 2025 financial performance demonstrates a strong revenue growth trajectory, driven by robust segmental performances and effective cost management, with a focus on expanding its medical technology solutions and optimizing operational efficiency.